Skip to main content

Table 2 Patients' characteristics – protocol schedules.

From: Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: The experience of the Tuscan Reference Centre

HILP Group

 

G-A

G-B

G-C

HT schedule

 

MILD

TRUE

TRUE

HILP = n

 

60

74

108

Period

 

1984–1989

1988–1994

1990–2007

Gender: M/F

 

16/44

29/45

29/79

Age: median yrs (range)

 

55.1 (24–76)

52 (20–70)

60.6 (30–78)

Mean body weigh: kg (range)

 

68.3 (45/97)

69.8 (50–96)

70 (45–138)

Mean limb volume: lt (range)

 

10.4 (7.5–14)

11.1 (8.2–16)

10.3 (7.5–20.5)

Stage I-II: HILP = n (%)

 

34 (56.7)

59 (79.8)

4 (3.7)

Stage III-IV: HILP = n (%)

 

26 (43.3)

15 (20.2)

104 (96.3)

HT grade

 

38–40°C

40–41.8°C

40–41.8°C

L-PAM

mg/lt limb vol

10

10

10

 

mg for 1 lt of prime

10

10

10

 

mg/lt limb vol

-

-

5 (add. bolus)

Mean L-PAM mg (range)

 

114.1 (85–150)

122.9 (92–195)

163 (120–240)

D-act. 1 mg: HILP = n (%)

 

10 (16.6)

15 (20.2)

43 (39.8)

First HILP = n (%)

 

55 (91.7)

70 (94.6)

88 (81.5)

Second HILP = n (%)

 

5 (8.3)

4 (5.4)

20 (18.5)